[
  {
    "ts": null,
    "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2025 Update",
    "summary": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2025 Update",
    "url": "https://finnhub.io/api/news?id=e27504393d6270f71f4779aed94b422dee3a3fcabc889d6582ddb2468c20c3d3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747865679,
      "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2025 Update",
      "id": 134631523,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e27504393d6270f71f4779aed94b422dee3a3fcabc889d6582ddb2468c20c3d3"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Merck & Co. Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=41908d3b312da3360239d459bc62b30cc65593bae109c4f544b510a81b15d659",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747845240,
      "headline": "Merck & Co. Inc. stock underperforms Wednesday when compared to competitors",
      "id": 134634136,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=41908d3b312da3360239d459bc62b30cc65593bae109c4f544b510a81b15d659"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Merck & Co., Inc. (MRK) on Value Investing Subreddit Page by CompanyCharts. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $77.23 as of May 19th. MRK’s trailing and forward P/E were 11.23 and 8.64 respectively according to Yahoo […]",
    "url": "https://finnhub.io/api/news?id=d6cead719342c1272241e68e48a7e31dd87d06a8613835fa95626117699dfa4f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747841299,
      "headline": "Merck & Co., Inc. (MRK): A Bull Case Theory",
      "id": 134628367,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Merck & Co., Inc. (MRK) on Value Investing Subreddit Page by CompanyCharts. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $77.23 as of May 19th. MRK’s trailing and forward P/E were 11.23 and 8.64 respectively according to Yahoo […]",
      "url": "https://finnhub.io/api/news?id=d6cead719342c1272241e68e48a7e31dd87d06a8613835fa95626117699dfa4f"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Looks Like A Great Play At Current Valuations",
    "summary": "Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals versus peers.",
    "url": "https://finnhub.io/api/news?id=a926781e85b4794d8dfc4b02946c645e3c548a2b3de04af57250c83422ef2b47",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747830005,
      "headline": "Pfizer Looks Like A Great Play At Current Valuations",
      "id": 134626678,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359138081/image_1359138081.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals versus peers.",
      "url": "https://finnhub.io/api/news?id=a926781e85b4794d8dfc4b02946c645e3c548a2b3de04af57250c83422ef2b47"
    }
  }
]